[Federal Register Volume 62, Number 240 (Monday, December 15, 1997)]
[Notices]
[Page 65706]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-32636]


=======================================================================
-----------------------------------------------------------------------

FEDERAL TRADE COMMISSION

[Dkt. C-3726]


Baxter International Inc.; Prohibited Trade Practices, and 
Affirmative Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent Order.

-----------------------------------------------------------------------

SUMMARY: In settlement of alleged violations of federal law prohibiting 
unfair or deceptive acts or practices and unfair methods of 
competition, this consent order requires, among other things, Baxter 
International (``Baxter''), an Illinois-based corporation, to divest 
its Autoplex product to a Commission-approved buyer, and to license 
Immuno International AG's (``Immuno'') product in development to a 
Commission-approved licensee within four months of the date Baxter 
signs the consent. This would resolve antitrust concerns raised by the 
$463 million acquisition of Immuno by Baxter, which both manufacture a 
wide variety of biologic products derived from human blood plasma.

DATES: Complaint and Order issued March 24, 1997.\1\
---------------------------------------------------------------------------

    \1\ Copies of the Complaint and the Decision and Order are 
available from the Commission's Public Reference Branch, H-130, 600 
Pennsylvania Avenue, N.W., Washington, D.C. 20580.

FOR FURTHER INFORMATION CONTACT: Pamela Taylor, FTC/S-2308, Washington, 
---------------------------------------------------------------------------
D.C. 20580. (202) 326-2237.

SUPPLEMENTARY INFORMATION: On Friday, January 3, 1997, there was 
published in the Federal Register, 62 FR 408, a proposed consent 
agreement with analysis In the Matter of Baxter International Inc., for 
the purpose of soliciting public comment. Interested parties were given 
sixty (60) days in which to submit comments, suggestions or objections 
regarding the proposed form of the order.
    No comments having been received, the Commission has ordered the 
issuance of the complaint in the form contemplated by the agreement, 
made its jurisdictional findings and entered an order to divest, as set 
forth in the proposed consent agreement, in disposition of this 
proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46, Interpret or apply sec. 5, 38 
Stat. 719, as amended; sec. 7, 38 Stat. 731, as amended; 15 U.S.C. 
45, 18)
Benjamin I. Berman,
Acting Secretary.
[FR Doc. 97-32636 Filed 12-12-97; 8:45 am]
BILLING CODE 6750-01-M